和铂医药（上海）有限公司 Harbour BioMed
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Harbour BioMed Reports Full Year 2023 Financial Results 2024-03-28 22:10
Nona Biosciences Enters into Collaboration Agreement with Boostimmune in Antibody-Drug Conjugate Development 2024-02-27 09:23
Harbour BioMed Announces IND Clearance for HBM9027 in the U.S. 2024-01-24 12:40
Harbour BioMed Announces Positive Profit Alert 2024-01-19 12:52
Nona Biosciences Enters into a Global License Agreement with Pfizer for HBM9033, an MSLN-Targeted Antibody-Drug Conjugate (ADC) 2023-12-15 07:30
Nona Biosciences Announces Collaboration with Evive Biotech to Accelerate Antibody Discovery 2023-12-11 09:00
Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics 2023-12-04 13:19
Nona Biosciences Announces Strategic Collaboration with GeneQuantum Healthcare to Empower Early Discovery of Next-Generation Bioconjugates 2023-11-13 16:04
Nona Biosciences and INGENIA Therapeutics Enter into Collaboration Agreement 2023-10-13 23:26
Nona Biosciences Expands Antibody Discovery Collaboration with BeiGene 2023-09-14 16:00
Harbour BioMed Announces 2023 Interim Results 2023-08-28 17:08
Harbour BioMed Announces US IND Clearance of Its First ADC Program HBM9033 in Solid Tumors 2023-08-28 16:30
Harbour BioMed Appoints Dr. Albert R. Collinson as Independent Non-Executive Director 2023-08-08 16:10
Nona Biosciences Announces Business Update of Collaboration on Antibody Drug Conjugate (ADC) with DualityBio 2023-07-14 08:29
Harbour BioMed Announces 2023 Interim Results Positive Profit Alert with the Enhancement of Value Driven by Innovation 2023-07-13 18:11
Harbour BioMed Announces Biologics License Application Acceptance of Batoclimab for Treatment of Generalized Myasthenia Gravis by NMPA 2023-06-29 21:26
Nona Biosciences Appoints Steve Arkinstall, D. Phil., as Chief Scientific Advisor 2023-06-07 09:00
Harbour BioMed Announces First Patient Dosed in Phase I Study of First-in-Class Anti-B7H7 (HHLA2) Antibody HBM1020 2023-06-05 09:01
Harbour BioMed Reports Results of Phase Ib Clinical Trial of Porustobart in Combination of Toripalimab in Patients with Hepatocellular Carcinoma at ASCO 2023 2023-05-29 09:42
Nona Biosciences Enters into Antibody Discovery Agreement with OPKO Health's ModeX Therapeutics 2023-05-23 13:00
1 2 3 4 5